Pacira BioSciences (PCRX) Earnings Date & Reports

Industry: @Pharmaceuticals Other

A.I. Advisor

published Earnings

PCRX is expected to report earnings to fall 19.06% to 72 cents per share on October 31

Pacira BioSciences PCRX Stock Earnings Reports

Q3'24

Est.

$0.72

Q2'24

Beat

by $0.20

Q1'24

Est.

$0.62

Q4'23

Beat

by $0.01

Q3'23

Missed

by $0.06

The last earnings report on July 30 showed earnings per share of 88 cents, beating the estimate of 68 cents. With 632.73K shares outstanding, the current market capitalization sits at 1.36B.

View a ticker or compare two or three

Compare

PCRX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For PCRX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for PCRX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a manufacturer of injectable therapeutic products

Industry PharmaceuticalsOther

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

5401 West Kennedy Boulevard

Phone

+1 813 553-6680

Employees

713

Web

https://www.pacira.com